Cargando…
Phosphodiesterase-4 Inhibition in Psoriasis
Psoriasis is a chronic immune-mediated inflammatory disorder. Phosphodiesterase-4 (PDE-4) is an enzyme that mediates inflammatory responses and plays a role in psoriasis pathogenesis. PDE-4 degrades its substrate cyclic adenosine monophosphate (cAMP) to adenosine monophosphate (AMP), which subsequen...
Autores principales: | Milakovic, Milica, Gooderham, Melinda J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982714/ https://www.ncbi.nlm.nih.gov/pubmed/33763335 http://dx.doi.org/10.2147/PTT.S303634 |
Ejemplares similares
-
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015) -
Management of scalp psoriasis: current perspectives
por: Blakely, Kim, et al.
Publicado: (2016) -
Phosphodiesterase 4 Inhibition in the Treatment of Psoriasis, Psoriatic Arthritis and Other Chronic Inflammatory Diseases
por: Wittmann, Miriam, et al.
Publicado: (2013) -
Diagnosis of Generalized Pustular Psoriasis
por: Fujita, Hideki, et al.
Publicado: (2022) -
Clinical Implication of Phosphodiesterase-4-Inhibition
por: Schick, Martin Alexander, et al.
Publicado: (2022)